In a multivariate analysis including KI67LI, hormone receptor status, HER2 status, pT stage, BRE grade and nodal stage, p16 expression predicted overall survival independently from these parameters in 800 analyzable cancers (p = 0.0304, Table 3). Here, NR4A1 is linked to cancer.